Vaccine Info

mAb114 (Ebola)

mAb114 is a single monoclonal antibody developed by NIAID.  

mAb114, a single monoclonal antibody, binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cells.

Two clinical trials are underway for this treatment.   

Updated
April 8th, 2019